Death with Dignity | Michael L. Pearl, MD, FACOG, FACS
Some patients influence our lives in ways we never expect.
In July, 1989, I was a brand new chief resident, learning to manage an extremely busy and complicated gynecologic oncology service. With four active gynecologic oncologists, lengths of stay averaging a week and minimal outpatient chemotherapy, our inpatient census typically numbered in the 20’s.
Medicinal cannabis: The genie is out of the bottle | Christopher Lutman, MD
In 1996, Proposition 215 was passed by the citizens of California, which became the first state to legalize the usage of cannabis for medical purposes. Since that historic ballot measure, medicinal cannabis has now become legal in 23 states. It is also legal in the District of Columbia and the overseas territories of Guam and Puerto Rico.
SGO Annual Meeting: A Latin American perspective | Erick Estrada, MD
Latin America is a region with tremendous potential, diverse cultures and languages, our own unique problems but a very genuine mission to eradicate women´s cancer. The local economy plays an important role in dictating access to health care but we are determined to overcome any barriers, because our mission is based upon knowledge instead of bureaucracy.
#gyncsm – A Growing Community | Dee Sparacio
In September 2013, I wrote about the establishment of the #gyncsm (gynecologic cancer social media) monthly tweet chat. Over the past year, #gyncsm discussed a variety of topics relevant to the gynecologic cancer community. During the hour-long online discussion we asked four to five questions on each month’s topic. At the conclusion of each chat, we posted the questions, a chat transcript and links to the resources mentioned during the chat on our blog (gyncm.blogspot.com).
My Gift of Hope | Linda Ryan
As a three-time cancer survivor, I am more aware of how much meaning my life has now. Not only how precious life is and how thankful I am to be alive, but also of the opportunity to give back.
At the Center of it All | Dee Sparacio
Over the past nine years I have seen an increase in the number of non-profit organizations whose mission is to raise awareness of gynecologic cancers and funds for research. There are national organizations and many local gynecologic cancer organizations that consistently raise awareness about the risks and symptoms of gynecologic cancers via TV, radio, print, Twitter and Facebook. Other non-profits fund research host dinners, walks and runs, teas, and auctions. This private funding has been so important the past few years as government funding of cancer research has been reduced.
SGO Obesity Toolkit can empower patients | Lauren S. Prescott, MD
In 1997, the World Health Organization formally recognized obesity as a global epidemic. Seventeen years later, we are still facing alarming increases in obesity. As a resident in obstetrics and gynecology and now a fellow in gynecologic oncology, I have struggled to adequately address obesity and weight management with many of my patients.
Tweeting at the Meeting | B.J. Rimel, MD
Twitter is an online news and social media feed that uses brief posts (140 characters) to communicate and connect people with information. That little blue bird icon on the side of the news story you are reading or next to the online menu that you just looked up is your direct link to Twitter. The journalist who wrote the story and the chef who made the menu want you to share your thoughts about their content. So does the SGO!
First Impressions from the SGO Winter Meeting | B.J. Rimel, MD
Breckenridge, Colorado, was the site of this year’s SGO Winter Meeting on Feb. 20-22. A record-breaking 216 Society members attended despite of (or perhaps because of) the immense amount of fresh snow (over 280% of snowpack). I must confess that this was my first Winter Meeting. Not being a particularly athletic soul, racing downhill at high speed has never had much appeal. That said, I will be back next year. It’s a GREAT meeting.
End of GOG Marks a New Beginning | B.J. Rimel, MD
Last month I joined hundreds of gynecologic oncologists in making our yearly pilgrimage to San Diego, CA. For the past four decades, members of our subspecialty would assemble for the Gynecologic Oncology Group (GOG) semi-annual meeting. The GOG has conducted the vast majority clinical trials in gynecologic cancer and the group is responsible for most of the treatment advances in these diseases over the last 45 years. Now, due to major changes in the way that the National Institutes of Health (NIH) funds clinical trials, we are part of a larger group. We have joined up with the National Surgical Adjuvant Breast and Bowel Project (NSABP) and the Radiation Therapy Oncology Group (RTOG) to create…wait for it…NRG Oncology.